HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 231.41 billion as of June 10, 2026. Its market cap has decreased by -64.75% in one year.

Market Cap

231.41B

Enterprise Value

277.17B

Revenue

67.56B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,500.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 231.41B, an increase of 118.71%. That is a compound annual growth rate of 4.94%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2026	233.26B	-7.39%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Proteina	384.58B
SillaJen	350.54B
Genomictree	289.09B
BINEX	257.97B
Anterogen.Co.,Ltd.	252.65B
GC Cell	247.95B
NeoImmuneTech	247.66B
EASY BIO,Inc.	217.68B

Market Cap Rankings